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To the Editor: Bartonella are 
fastidious hemotropic gram-negative 
bacteria with a worldwide distribu-
tion. In Thailand, Bartonella species 
have been demonstrated in mamma-
lian hosts, including rodents, cats and 
dogs, and in potential vectors, includ-
ing fl eas (1–4). However, data on hu-
man infection have been limited to case 
reports (5,6) and 1 seroprevalence sur-
vey, which found a 5.5% prevalence 
of past B. henselae infection (7). No 
studies have systematically assessed 
the frequency, clinical characteristics, 
or epidemiology of human Bartonella 
infections in Thailand.
We conducted a prospective 
study to determine causes of acute 
febrile illness in 4 community hospi-
tals, 2 in Chiang Rai (northern Thai-
land) and 2 in Khon Kaen (northeast-
ern Thailand). We enrolled patients 
>7 years of age with a temperature 
>38°C who were brought to study 
hospitals for treatment from Febru-
ary 4, 2002, through March 28, 2003. 
Patients were excluded if they had a 
history of fever for >2 weeks or an in-
fection that could be diagnosed clini-
cally. Acute-phase serum samples 
were collected at the time of enroll-
ment and convalescent-phase serum 
samples 3–5 weeks later. We enrolled 
nonfebrile control patients >14 years 
of age who had noninfectious con-
ditions; acute-phase serum samples 
were collected. Clinical information 
was abstracted from patient charts. 
Nurses conducted physical examina-
tions and personal interviews to col-
lect information on patients’ demo-
graphic characteristics, exposures to 
animals, and outdoor activities.
Serum samples were tested for 
immunoglobulin (Ig) G antibodies to 
Bartonella spp. by immunofl uorescent 
antibody assay at the Bartonella Labo-
ratory of the Centers for Disease Con-
trol and Prevention, Fort Collins, CO, 
USA. Strains used for antigen produc-
tion were: B. elizabethae (F9251), B. 
henselae (Houston-1), B. quintana 
(Fuller), and B. vinsonii subsp. vinsonii 
(Baker). Homologous hyperimmune 
serum specimens were produced in 
BALB/c mice as previously described 
(8). Bartonella infection was consid-
ered confi rmed in febrile patients who 
had a >4-fold rise in IgG antibody 
titers and a convalescent-phase titer 
>64. Probable infection was defi ned 
as 1) a 4-fold antibody titer rise but 
convalescent-phase titers of 64, or 2) 
high and stable titers (>512 in acute-
phase and convalescent-phase serum 
samples), or 3) acute-phase titer >512 
with a >4-fold titer fall. Paired serum 
samples from febrile patients were 
also tested for serologic evidence of 
other common causes of febrile illness 
in Southeast Asia.
Febrile patients with acute-phase 
and convalescent-phase IgG antibody 
titers <128 were considered not to have 
Bartonella infection; we compared 
demographic and clinical character-
istics of these patients to Bartonella-
infected patients. To evaluate potential 
risk factors, we compared Bartonella-
infected case-patients >14 years of age 
without serologic evidence of other in-
fections (n = 20) to nonfebrile controls 
with IgG to Bartonella <128 (n = 70). 
Age adjusted odds ratios (AORs) with 
95% confi dence intervals (CIs) were 
calculated.
Serologic testing was complet-
ed on paired serum samples for 336 
(46%) of 732 febrile patients en-
rolled; 92 (27%) had serologically 
confi rmed (50) or probable (42) Bar-
tonella infections. Thirty-fi ve (38%) 
of these 92 had serologic evidence of 
infection with another pathogen. The 
remaining 57 Bartonella-infected 
case-patients (34 confi rmed, 23 prob-
able) had a median age of 19 years 
(range 7–72 years); 65% were males, 
47% were students, and 35% were 
rice farmers. Common clinical char-
acteristics of Bartonella-infected pa-
tients included myalgias (83%), chills 
(79%), and headache (77%). Thirty 
(60%) patients had anemia (hemoglo-
bin level <13 mg/dL); 18 (32%) had 
a hemoglobin level <12 mg/dL, and 
4 (7%) had <11 mg/dL. When com-
pared with 193 febrile patients with-
out Bartonella infection, the 57 Bar-
tonella-infected patients were similar 
in age and sex but were more likely to 
be rice farmers and were more likely 
to have leukocytosis (Table). Com-
pared with the 70 nonfebrile controls, 
Bartonella-infected case-patients 
were more likely to report tick ex-
posure (32% vs. 7.9%; AOR = 5.6, 
95% CI 1.5–21) and outdoor activi-
ties (55% vs. 31%; AOR = 2.7, 95% 
CI 1.0–7.4) during the 2 weeks before 
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illness onset. Prevalence of reported 
rat exposure and animal ownership 
(cats, dogs, pigs, cows, or buffaloes) 
was similar among case-patients and 
controls.
We describe the frequency and 
clinical characteristics of acute Barto-
nella infection among febrile patients 
in Thailand. Over 25% of patients 
with undifferentiated febrile illness 
had serologic evidence of Bartonella 
infection (including 15% serologically 
confi rmed). Our fi ndings indicate that 
Bartonella infections may be common 
and underrecognized causes of acute 
febrile illness in rural Thailand. Al-
though our results are limited by lack 
of culture confi rmation, we used con-
servative case defi nitions for serologic 
diagnosis and therefore believe that 
most cases represent true Bartonella 
infections. The common clinical fea-
tures of anemia and leukocytosis and 
the frequent tick exposure and outdoor 
activity are consistent with known fea-
tures of Bartonella infections and lend 
support to serologic fi ndings. Because 
of the potential for serologic cross-
reactivity between Bartonella species, 
we did not attempt species identifi -
cation. The case-control study was 
therefore limited by grouping case-
patients that were likely infected with 
different Bartonella species for which 
risk factors may differ. Such studies 
could lead to meaningful recommen-
dations for prevention and control of 
Bartonella infections. Additional epi-
demiologic and transmission studies 
are needed to improve understanding 
of risk factors, identify key animal 
reservoirs and vectors, and ascertain 
transmission dynamics. 
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Table. Demographic and clinical characteristics of febrile patients with Bartonella





patients,† n = 57 
No. (%) non–case-
patients,‡ n = 193 
p
value
Median age, y (range) 19 (7–72) 20 (7–79) 0.9
Male sex 37 (64.9) 113 (58.5) 0.4
Occupation
 Student 27 (47.4) 84 (43.5) 0.6
 Rice farmer 20 (35.1) 40 (20.7) 0.03
 Business 3 (5.3) 13 (6.7) 0.7
 Other§ 7 (12.3) 56 (29.0) 0.01
Signs and symptoms 
 Headache 44 (77.2) 161 (83.4) 0.3
 Eye pain 17 (29.8) 58 (30.1) 1.0
 Myalgias 47 (82.5) 141 (73.1) 0.1
 Extremity pain 39 (68.4) 115 (59.6) 0.2
 Joint pain 26 (45.6) 74 (38.3) 0.3
 Vomiting 22 (38.6) 80 (41.5) 0.7
 Abdominal pain 12 (21.1) 64 (33.2) 0.08
 Rash 7 (12.3) 17 (8.8) 0.6
 Lymphadenopathy 9 (15.8) 24 (12.4) 0.5
Laboratory results 
 Anemia (Hb <13 mg/dL) 30 (60.0) 93 (50.3) 0.2
 Thrombocyte count <100,000/mm3 5 (8.9) 14 (7.4) 0.7
 Leukopenia 
(leukocytes <5,0 300/mm )
10 (17.5) 63 (32.6) 0.03
 Leukocytosis 
(leukocytes >11 3,000/mm )
20 (35.1) 33 (17.1) <0.01
 Creatinine >1.5 mg/dL 5 (8.9) 12 (6.2) 0.5
 Bilirubin >1.3 mg/dL 6 (10.7) 19 (9.8) 0.8
 Alkaline phosphatase >121 IU/L 36 (64.3) 132 (68.8) 0.5
 AST >36 IU/dL 18 (32.1) 88 (45.6) 0.07
 ALT >36 IU/dL 9 (16.1) 50 (25.9) 0.1
*Hb, hemoglobin; AST, aspartate aminotransferase;  ALT, alanine aminotransferase. 
†Excluded Bartonella-infected patients with serologic evidence of infection with other common 
pathogens (dengue virus, Leptospira, or Burkholderia pseudomallei; n = 35). 
‡Febrile patients with acute-phase and convalescent-phase immunoglobulin G titer against 
Bartonella species <128. 
§Other occupation includes housewife, government officer, day laborer, or construction worker. 
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To the Editor: Cholera is a ma-
jor public health problem in countries 
where access to safe water and adequate 
sanitation cannot be guaranteed for all. 
Vibrio cholerae serogroups O1 and 
O139 are the causative agents of cholera 
(1). One of the most powerful virulence 
factors in this organism is cholera toxin 
encoded by the ctxAB gene, located on 
the CTX prophage. V. cholerae O1 is 
classifi ed into 2 biotypes, classical and 
El Tor. The El Tor type of V. cholerae 
O1 is responsible for the ongoing sev-
enth worldwide pandemic of cholera 
(2). The sequence of ctxB of a certain 
strain has been believed to correspond 
to its biotype; that is, a biotype classical 
strain has classical type ctxB, and a bio-
type El Tor strain has El Tor type ctxB. 
However, recent research studies sug-
gest that novel types of V. cholerae O1, 
hybrid strains, and altered El Tor or El 
Tor variant strains (1,3) are emerging. 
Altered El Tor or El Tor variant strains 
are biotype El Tor but produce classi-
cal cholera toxin (3,4). Recent reports 
suggest that this type of V. cholerae O1 
is spreading to many areas of the world 
(5).
In December 2007–January 2008, 
a cholera outbreak occurred in Xe-
kong Province in southeastern Laos, 
in the Mekong Basin. The fi rst case of 
the outbreak was detected on Decem-
ber 23, 2007. The outbreak spread to 
10 villages and lasted through January 
2008. Specifi cally, in the Thateng Dis-
trict, 117 cases occurred and 2 deaths 
were reported. The sources of the out-
break were suspected to be regularly 
used water. In October 2007, 2 months 
before the outbreak, 3 sporadic cases 
of V. cholerae infection had been iden-
tifi ed in Vientiane (the capital city) and 
Xaignabouri Province in north-central 
and northwestern Laos, respectively. 
The outbreak investigation in the Xe-
kong Province identifi ed no linkage 
between these sporadic cases and the 
outbreak cases. 
In this study, we analyzed 18 V. 
cholerae isolates obtained in 2007: 
3 were from patients with sporadic 
cases, and 15 were from the Xekong 
outbreak (13 from patients and 2 
from water samples). All the isolates 
were serotype O1 Ogawa and biotype 
El Tor, but their ctxB types were clas-
sical, according to the method pre-
viously described (6). This fi nding 
indicates that they were the type of 
altered El Tor.
We used pulsed-fi eld gel electro-
phoresis (PFGE) to investigate rela-
tionships between the isolates accord-
ing to the PulseNet protocol (7). All 18 
isolates from the sporadic cases and the 
outbreak in 2007 displayed profi les in-
distinguishable from each other (Fig-
ure). We also compared 2 additional V. 
cholerae O1 isolates, 1 from a patient 
in Vientiane in 1998 and another from 
a patient in Louangphabang in 2000 
(Figure). The profi les of the isolates 
obtained in 1998 and 2000 clearly 
differed from those obtained in 2007. 
These results indicate that all isolates 
from sporadic and outbreak cases in 
2007 were likely from the same source 
of contamination, although extensive 
epidemiologic investigation did not 
identify any common source.
Nguyen et al. characterized the 
isolates from a cholera outbreak in 
Vietnam from late 2007 to early 2008 
(8). Their report suggests that the iso-
lates from the outbreaks in Vietnam 
and Laos shared the same elements 
of the CTX prophage. Our study 
suggests a common source for the 
strains of sporadic cases in Vientiane 
and Xaignabouri Province in Octo-
ber 2007 and those of the outbreak in 
Xekong Province in December 2007. 
Molecular typing suggests that a novel 
clone of V. cholerae O1 is being dis-
seminated along the Mekong Basin. 
However, no epidemiologic associa-
tion has been identifi ed so far. Thus, 
a more extensive regionwide surveil-
lance system is needed to identify and 
control V. cholerae infection in Laos 
and neighboring countries.
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